New oral drug tested for aggressive leukemia that has returned
Disease control
Recruiting now
This early-stage trial is testing the safety and proper dosing of an experimental oral medication called MRX-2843. It is for adolescents and adults whose acute leukemia has come back or has not responded to previous treatments. The main goal is to find the highest dose that can b…
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC